drugset / Trial / NCT00662077

Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort

NCT00662077 ↗

Phase 4 Withdrawn Germans Trias i Pujol Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This project wills to determine the incidence of osteoporosis in our population of HIV-infected patients and to assess the efficacy and security of ibandronate, whose efficacy in post-menopausal women has already been proved.

Timeline

Start
—
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped (Business): “Financial difficulties”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibandronate Other / unclassified 3 mg Intravenous